Acne is a multifactorial condition with a significant inflammatory component. While the proliferation of Cutibacterium acne primarily causes acne, several genetic factors influence the severity of the condition, age of onset, its manifestation, and the formation of scars and hyperpigmentation after acne.
Acne affects 9.4% of people worldwide, that is, 54% of women over 25. They can cause long-term adverse psychosocial and physical effects, such as scar tissue formation or post-inflammatory hyperpigmentation. Delayed acne treatment can lead to permanent consequences. Although acne is a treatable condition, the type of treatment and the stage at which this approach is used affect the final outcome.
Prescribing the right treatment at the right time is crucial for achieving optimal results, and avoiding the need for prolonged and expensive treatments.
How does AcneTest work?
According to the instructions, a DNA sample is collected and sent for analysis after registration. Results are available within 4-5 weeks.
The report includes a summary of the patient's characteristics, a complete genetic analysis, an explanation, and proposed personalized formulations.
AcneTest analyzes 180 genetic variations associated with acne predisposition and response to pharmacological treatment. It combines genetic data with relevant patient history through an advanced algorithm to assist healthcare professionals in selecting the best form of therapy.
What is being assessed?
AcneTest analyzes polymorphisms in 60 single nucleotide polymorphisms (SNPs) in genes related to sebum production, pigmentation, hormone conversion, scar tissue formation, metabolism, drug response, and dietary response.
The AcneTest report includes personalized treatment based on the analysis of the following categories:
- Predisposition to acne
- Skin condition and inflammation
- Nutritional approach
- Pharmacogenomics
- Hormonal approach